Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) Ends Week on Huge Volume.

New York, NY -- (SBWIRE) -- 01/27/2013 -- Growing Stock Report iniates a Nasdaq Volume Watch List and Investor Poll for the following stock: Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH)

Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) Closed Friday down (-10.09%) on 15,345,434 Shares Traded.

Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) announced the pricing of an underwritten public offering of 60,606,061 shares of its common stock, offered at a price of $0.66 per share. The Company estimates that the gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Anthera, will be $40.0 million. The offering is expected to close on or about January 30, 2013, subject to customary closing conditions. In addition, Anthera has granted the underwriters a 30-day option to purchase up to an additional 9,090,909 shares of common stock. The Company intends to use the net proceeds from the offering for general corporate purposes. Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) is currently down (-92.40%) from it's 52-Week High of $8.42 which has prompted Growing Stock Report to Add it to their Nasdaq Decliner Watch List and Investor Poll.

Get ANTH Poll & Consensus Report Here: http://www.growingstockreport.com/Survey.aspx?stock=ANTH

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com